Processa Pharmaceuticals, Inc.
USD2.24
+0.02 (+0.90%)
CEO
George K. Ng
IPO Date
2014-03-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.21
Prev. Close
$2.22
Day Low
$2.20
Day High
$2.35
52W Low
$1.67
52W High
$14.25
Market Cap
$0.01B
Volume
0.10M
| 2,106 |
| $1.93 |
| 1 Jul 2026 | Ng George K | director, officer: Chief Executive Officer | P-Purchase | Acquired | 3,057 | $1.93 |
| 1 Jul 2026 | SKIBSTED RUSSELL | Chief Financial Officer | P-Purchase | Acquired | 3,277 | $1.93 |
| 1 Jul 2026 | Young David | director, officer: Pres. Research & Development | P-Purchase | Acquired | 2,531 | $1.93 |
| 30 Jun 2026 | Yorke Justin W | director | M-Exempt | Acquired | 203 | $0.00 |
| 30 Jun 2026 | Yorke Justin W | director | M-Exempt | Disposed | 203 | $0.00 |
| 30 Jun 2026 | Pannu Geraldine | director | M-Exempt | Acquired | 203 | $0.00 |
| 30 Jun 2026 | Pannu Geraldine | director | M-Exempt | Disposed | 203 | $0.00 |
| 30 Jun 2026 | Neal James R | director | M-Exempt | Acquired | 203 | $0.00 |